Search
Powerful Childhood Cancer Treatment Holds Promise--and Poses Hazards
- OPACC
- Sep 12, 2017
- 1 min read
A new type of cancer therapy—recently approved by the U.S. Food and Drug Administration for children with leukemia who run out of options—is changing medical practice and has triggered excitement in the normally reserved world of cancer science.
Recent Posts
See AllThe FDA has granted Rare Pediatric Disease Designation for NEO100 in the treatment of pediatric-type diffuse high-grade gliomas, a type...
Untreated growth hormone deficiency was associated with neurocognitive impairment and reduced physical functioning among adult survivors...
A Phase I clinical trial demonstrated that a targeted approach to treating a deadly brain tumor in children called diffuse intrinsic...